Koers Satsuma Pharmaceuticals, Inc.
Aandelen
STSA
US80405P1075
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08-06-23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01-01-17 |
Chief Tech/Sci/R&D Officer | 63 | 01-07-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08-06-23 |
Director/Board Member | 64 | 08-06-23 | |
Ken Takanashi
BRD | Director/Board Member | 59 | 01-06-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,56% | 108 mld. | |
+10,02% | 104 mld. | |
+7,77% | 23,66 mld. | |
-11,91% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-14,02% | 16,19 mld. | |
+4,61% | 13,72 mld. | |
+35,05% | 12,22 mld. |